GuidelineZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026
[Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)].
Guideline in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Febrile neutropenia is associated with a high risk of infection-related mortality if appropriate antimicrobial therapy is not initiated promptly. In recent years, the diagnostic and therapeutic concepts for febrile neutropenia have substantially advanced, along with new epidemiological data on pathogens, particularly drug-resistant bacteria. According to evidence-based medical evidence from both domestic and international sources, the Chinese Society of Hematology, Chinese Medical Association and Chinese Medical Doctor Association, Hematology Branch organized experts in related fields to update the 2020 edition guidelines. The GRADE method was employed to develop revised recommendations for evidence quality assessment and recommendation strength grading.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.